Buchang Group
Buchang Pharma (????) provides pharmaceutical products, research, and sales in China.
Launch date
Employees
Market cap
CAD3.1b
Enterprise valuation
CAD3.5b (Public information from Sep 2024)
Share price
CNY15.08 603858.SS
Xi'an Shaanxi (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 14.3b | 16.0b | 15.8b | 15.0b | 13.2b |
| % growth | - | 12 % | (2 %) | (5 %) | (11 %) |
| EBITDA | 2.9b | 2.9b | 2.5b | 2.4b | 1.8b |
| % EBITDA margin | 20 % | 18 % | 16 % | 16 % | 14 % |
| Profit | 1.9b | 1.9b | 1.3b | (1.7b) | 319m |
| % profit margin | 14 % | 12 % | 8 % | (11 %) | 2 % |
| R&D budget | 505m | 533m | 409m | 284m | 335m |
| R&D % of revenue | 4 % | 3 % | 3 % | 2 % | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
| N/A | N/A | IPO | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
